Thinking about an ODC cannabis licence in Australia? Here is what the Narcotic Drugs Act 1967 actually requires, how the Single Licence works, and what trips up most applicants.
An ODC cannabis licence in Australia is the federal authorisation that lets a Licensed Producer cultivate, produce, or manufacture medicinal cannabis under the Narcotic Drugs Act 1967. The Office of Drug Control issues it, the Therapeutic Goods Administration regulates everything that happens to the product downstream of cultivation, and your state or territory Poisons authority controls wholesale supply. This guide walks through the licence structure, the Fit and Proper Person test, the 2021 Single Licence reform, and the state authorisations you also need before product can legally move.
It is written for compliance leads, QA managers, and would-be applicants. Every regulatory reference comes from a primary source: the Narcotic Drugs Act 1967, ODC guidance, or the 2021 amending legislation. Read it end-to-end before you start your application, or use it as a checkpoint against what you are doing today.
What Is the ODC and What Cannabis Activities Does It Licence?
The Office of Drug Control administers Commonwealth controls on narcotic and psychotropic substances, including all medicinal cannabis activities, under the Narcotic Drugs Act 1967. The Act implements Australia’s obligations under the Single Convention on Narcotic Drugs 1961. That treaty heritage explains the structure: licensing is centralised federally rather than at the state level, licensee-level data flows to the International Narcotics Control Board (INCB), and only cannabis may be grown on a licensed cultivation site.
An ODC cannabis licence (formally a Medicinal Cannabis Licence) authorises one or more of three activity types:
- Cultivation: growing cannabis plants, including propagation from seed or vegetative material.
- Production: harvesting, drying, trimming, and other post-harvest handling.
- Manufacture: processing cannabis into a therapeutic good (extraction beyond first crude extraction, formulation, dose-standardisation, packaging, labelling).
The ODC licence does not let you supply finished medicines to patients. That is a TGA matter, governed by supply pathways under the Therapeutic Goods Act 1989 (SAS, Authorised Prescriber Scheme, or ARTG listing). You also cannot wholesale or supply Schedule 4 or Schedule 8 cannabis inside a state or territory without the relevant state Poisons authorisation. ODC, TGA, and state authority run in parallel; satisfying one does not satisfy the others.
| Authority | What It Controls | Primary Statute |
|---|---|---|
| ODC | Cultivation, production, manufacture, quarterly reporting, security, import/export permits. | Narcotic Drugs Act 1967 (Cth) |
| TGA | Manufacturing licences, TGO 93 quality standard, PIC/S GMP v17 compliance, ARTG listing, supply pathways. | Therapeutic Goods Act 1989 (Cth) |
| State/Territory | Wholesale licences, S4/S8 possession and supply, state-specific security and storage requirements. | State Poisons or Drugs Acts |
What Are the Requirements for a Medicinal Cannabis Single Licence?
Before 2021, an operator needed up to three separate ODC licences (cultivation, production, manufacture) plus a research licence. The Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021 consolidated those into a single Medicinal Cannabis Licence. Commercial licences are now perpetual; non-commercial research licences remain time-limited. The licence is one document; the activities you may carry out under it are governed by separate permits attached to each authorised site.
Single Licence and Activity Permits
Every licensee holds one Medicinal Cannabis Licence plus an activity-specific permit for each site and each authorised activity. A cultivator with one greenhouse and one drying room may need a cultivation permit and a production permit for that site; adding a second farm needs a separate set of permits. The ODC treats each permitted site as an independent reporting unit, which is why quarterly reports under the ODC Cannabis Reporting Template are filed per site rather than per company.
The Single Licence is perpetual, but activity permits are not self-maintaining. Permit conditions can be varied, additional conditions imposed, and a permit can be suspended or cancelled independently of the licence. Most enforcement actions you read about in ODC press releases hit a permit, not the licence itself.
Supply Chain Viability and Single-Crop Compliance
Cultivator applicants must prove a supply chain at application: who will buy your raw material, and is that buyer GMP-licensed for downstream manufacture? The ODC will refuse a cultivation licence to an applicant without a credible downstream buyer. Unprocessed raw cannabis cannot leave the country. Exportable forms are limited to finished ARTG-listed medicines, cannabis extracts (including non-final dosage forms), and GMP-processed dose-standardised dried flower. Under the Single Convention on Narcotic Drugs 1961, only cannabis may be grown on a licensed cultivation site, which generally means a dedicated facility or a clearly partitioned, separately licensed parcel.
Get the Complete Australian LP Compliance Checklist
The full PDF expands on every ODC licensing item, lays out the TGA manufacturing standards, every TGO 93 limit, the PIC/S GMP v17 changes, the quarterly reporting calendar, and the security overlay items inspectors flag most. Drop it straight into your application pack.
Download Free GuideWhat Is the Fit and Proper Person Test Under the Narcotic Drugs Act 1967?
The Fit and Proper Person test is the ODC’s gatekeeping mechanism. It applies to every licensee, every individual nominated in the licence application, and every relevant business associate of the applicant. The test sits in sections 8A and 8B of the Narcotic Drugs Act 1967, and the ODC publishes a dedicated Guideline: Fit and proper persons and suitable staff that explains how the test is applied in practice. The ODC’s stated purpose is to keep criminal elements out of the licensing scheme.
The test is not a one-off question at application. The Secretary can reassess fit-and-proper status at any point during the licence lifecycle and is required by the Act to revoke a licence if the licensee or a relevant business associate is no longer fit and proper. In practice, three things follow:
- Disclosure is broad. Criminal history, civil judgments, insolvency, regulatory action by other agencies, and adverse media all need to be on the table at application. Surprises in the ODC’s own background checks weigh more heavily than the underlying fact you forgot to disclose.
- Business associates count. The test reaches beyond the named applicant to directors, ultimate beneficial owners, controlling shareholders, and other parties with influence over the licensed activities. A board change is a Fit and Proper event, not just a corporate-secretary filing.
- Financial probity matters. Capacity to comply with licence conditions includes financial capacity. Recent insolvency, undischarged judgments, and unresolved tax liabilities are all in scope.
Practically: build an internal notification matrix for every event that could trigger a Fit and Proper reassessment (change of director, new significant shareholder, criminal charge against a key person, insolvency). Treat reporting timelines under section 10K of the Act with the same urgency as a quarterly report deadline. Read the ODC’s Fit and Proper Persons guideline in full before listing anyone as a business associate.
Why Fit and Proper Failures Are Hard to Recover From
A revocation on Fit and Proper grounds is recorded against the licensee and the named individuals. It follows people into future applications, partnerships, and corporate roles. Reapplying after a revocation is materially harder than applying for the first time. The cheapest Fit and Proper finding is the one that never gets made because the disclosure happened proactively at application or as soon as the triggering event occurred.
How Did the 2021 Single Licence Reform Change Australian Cannabis Licensing?
The Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021 received Royal Assent on 24 June 2021 and commenced 24 December 2021. It implemented the recommendations of Professor John McMillan AO’s 2019 review of the Narcotic Drugs Act. Three structural changes matter for any LP today:
One Licence Instead of Three
The reform consolidated cultivation, production, and manufacture licences into a single Medicinal Cannabis Licence. The activities you may carry out are still controlled, but the control sits at the permit level rather than at the licence level. Most commercial LPs now hold one licence plus one or more activity permits attached to specific authorised sites.
Perpetual Commercial Licences
Commercial licences are now perpetual and do not require renewal. They can still be surrendered, suspended, or revoked under the Act (notably under section 10P, which sets out the grounds for revocation). Research-only licences remain time-limited. Producers sometimes misread “perpetual” as “set and forget”. It is not. The underlying document is perpetual; the obligations attached to it (quarterly reporting, Fit and Proper monitoring, security overlay maintenance, permit conditions) run continuously for the life of the licence.
Reduced but Not Removed Regulatory Burden
The reform removed a regular renewal cycle but did not lighten the day-to-day compliance load. The ODC still inspects at least once per licensee per 12-month period without notice. Quarterly reports are still due on the 15th of the month following each quarter end. Fit and Proper still applies continuously. For the full operational picture, see our Australian cannabis compliance checklist pillar guide.
Do You Also Need a State or Territory Authorisation?
Yes. The federal ODC licence authorises cultivation, production, and manufacture under the Narcotic Drugs Act 1967. It does not authorise wholesale, supply, or possession of Schedule 4 and Schedule 8 substances inside a state or territory. Each state and territory has its own Poisons or Drugs legislation controlling those activities. The state authorisation is required in addition to, not instead of, the ODC licence.
| State / Territory | Primary Legislation | Issuing Authority |
|---|---|---|
| New South Wales | Poisons and Therapeutic Goods Regulation 2008 | NSW Health Pharmaceutical Regulatory Unit |
| Victoria | Drugs, Poisons and Controlled Substances Act 1981 | Vic Department of Health Medicines and Poisons Regulation |
| Queensland | Medicines and Poisons Act 2019 | Qld Health Medicines Regulation and Quality |
| Other states/territories | Each has its own Poisons or Drugs Act | Relevant state/territory health department |
Practical implications: the state authorisation generally cannot be granted until the federal licence is in place, but engage the state authority early to scope requirements, fees, security overlay, and renewal cycle. State licences typically renew on their own cycle, separate from the ODC’s perpetual licence. Requirements vary materially between states; verify the current obligations with the relevant authority before assuming the federal compliance pack will satisfy them.
Export Permits Sit Separately Again
Export of cannabis from Australia requires a separate ODC export permit for each shipment, on top of the underlying licence and permits. The exporter must confirm the destination country’s import requirements are satisfied before goods leave Australia. Unprocessed raw cannabis remains prohibited from export. Recent ODC enforcement activity, including more than A$217,000 in infringement notices issued to multiple Australian licensees across 2025 and 2026, has touched export-related conduct as well as domestic reporting failures.
Frequently Asked Questions
How much does an ODC medicinal cannabis licence cost?
The ODC operates on a cost-recovery basis. Fees include an application fee, a licence assessment fee, and per-permit fees, with separate inspection fees recovered post-grant. The exact schedule is published in the ODC Cost Recovery Implementation Statement and updated periodically. Most applicants underestimate the indirect costs (legal review of corporate documents, criminal history checks across all named individuals, security overlay design, and consultant or in-house time to write the application), which together usually exceed the direct fees.
Is a TGA licence the same as an ODC licence?
No. The ODC issues your federal authorisation to grow, produce, or manufacture cannabis under the Narcotic Drugs Act 1967. The TGA issues a separate Licence to Manufacture Therapeutic Goods under the Therapeutic Goods Act 1989. If you manufacture cannabis into a medicine domestically you need both: ODC lets you possess and handle cannabis, TGA lets you manufacture it into a therapeutic good against PIC/S Guide to GMP version 17 and TGO 93.
What is a medicinal cannabis cultivation licence in Australia?
It is the activity-specific cultivation permit issued under your Medicinal Cannabis Licence. The licence is one document; the cultivation permit authorises you to grow cannabis at a specific site, with conditions covering security, record-keeping, quarterly reporting, supply obligations, and single-crop compliance. Most applicants apply for a cultivation permit and a production permit together because production (harvest, drying, trimming) is the natural next step.
How long does the ODC licence application take?
The ODC does not publish a guaranteed turnaround. Timelines depend on application completeness, corporate-structure complexity, Fit and Proper Person checks across named individuals and business associates, and the quality of the security overlay design. Twelve to eighteen months from initial application to permit grant is a realistic planning assumption for a first-time commercial cultivator.
Does an ODC licence cover both medical and recreational cannabis?
No. The Narcotic Drugs Act 1967 authorises medicinal cannabis activities only. Recreational cannabis remains prohibited at the Commonwealth level.
What happens if my licence is revoked on Fit and Proper grounds?
Revocation under section 10P of the Narcotic Drugs Act 1967 ends the authorisation to cultivate, produce, or manufacture. Stock on hand must be dealt with under ODC direction; staff cease licensed activities; site security obligations continue until decommissioning. The revocation is recorded against both the licensee and the named individuals, and reapplying is materially harder than first-time application.
Audit-Ready Compliance for Australian Licensed Producers
See how GrowerIQ helps Australian LPs automate ODC quarterly reporting, generate GMP-ready batch records, run deviation and CAPA tracking, and stay inspection-ready across every site and every shift.
Recommended For You
HighIQ Webinar Series: Powering Precision Production with Total Grow Control
May 8, 2026Portugal’s Cannabis Exports Triple: 42 Tonnes to Germany and Growing as Europe’s Processing Hub
April 22, 2026UK Medical Cannabis Prescriptions Surge 262%: 80,000 Patients and a GBP 500M Private Market
April 21, 2026About GrowerIQ
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.